224 related articles for article (PubMed ID: 25376447)
1. Clinical usefulness of diquafosol for real-world dry eye patients: a prospective, open-label, non-interventional, observational study.
Yamaguchi M; Nishijima T; Shimazaki J; Takamura E; Yokoi N; Watanabe H; Ohashi Y
Adv Ther; 2014 Nov; 31(11):1169-81. PubMed ID: 25376447
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.
Matsumoto Y; Ohashi Y; Watanabe H; Tsubota K;
Ophthalmology; 2012 Oct; 119(10):1954-60. PubMed ID: 22739038
[TBL] [Abstract][Full Text] [Related]
3. Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye.
Tauber J; Davitt WF; Bokosky JE; Nichols KK; Yerxa BR; Schaberg AE; LaVange LM; Mills-Wilson MC; Kellerman DJ
Cornea; 2004 Nov; 23(8):784-92. PubMed ID: 15502479
[TBL] [Abstract][Full Text] [Related]
4. Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial.
Park DH; Chung JK; Seo DR; Lee SJ
Am J Ophthalmol; 2016 Mar; 163():122-131.e2. PubMed ID: 26685791
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of topical diquafosol ophthalmic solution for treatment of dry eye: a systematic review of randomized clinical trials.
Wu D; Chen WQ; Li R; Wang Y
Cornea; 2015 Jun; 34(6):644-50. PubMed ID: 25909234
[TBL] [Abstract][Full Text] [Related]
6. Diquafosol ophthalmic solution 3 %: a review of its use in dry eye.
Keating GM
Drugs; 2015 May; 75(8):911-22. PubMed ID: 25968930
[TBL] [Abstract][Full Text] [Related]
7. Effects of Diquafosol Ophthalmic Solution on Quality of Life in Dry Eye Assessed Using the Dry Eye-Related Quality-of-Life Score Questionnaire: Effectiveness in Patients While Reading and Using Visual Display Terminals.
Utsunomiya T; Kawahara A; Hanada K; Yoshida A
Cornea; 2017 Aug; 36(8):908-914. PubMed ID: 28542084
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective, randomized, multicenter study.
Kamiya K; Nakanishi M; Ishii R; Kobashi H; Igarashi A; Sato N; Shimizu K
Eye (Lond); 2012 Oct; 26(10):1363-8. PubMed ID: 22878452
[TBL] [Abstract][Full Text] [Related]
9. Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition.
Shigeyasu C; Yamada M; Akune Y; Tsubota K
Jpn J Ophthalmol; 2015 Nov; 59(6):415-20. PubMed ID: 26310103
[TBL] [Abstract][Full Text] [Related]
10. A randomised, parallel-group comparison study of diquafosol ophthalmic solution in patients with dry eye in China and Singapore.
Gong L; Sun X; Ma Z; Wang Q; Xu X; Chen X; Shao Y; Yao K; Tang L; Gu Y; Yuan H; Chua WH; Chuan JC; Tong L
Br J Ophthalmol; 2015 Jul; 99(7):903-8. PubMed ID: 25631485
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease.
Mun Y; Kwon JW; Oh JY
BMC Ophthalmol; 2018 Sep; 18(1):237. PubMed ID: 30185156
[TBL] [Abstract][Full Text] [Related]
12. A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients.
Takamura E; Tsubota K; Watanabe H; Ohashi Y;
Br J Ophthalmol; 2012 Oct; 96(10):1310-5. PubMed ID: 22914501
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of treatment with diquafosol ophthalmic solution for aqueous-deficient dry eye.
Koh S; Ikeda C; Takai Y; Watanabe H; Maeda N; Nishida K
Jpn J Ophthalmol; 2013 Sep; 57(5):440-6. PubMed ID: 23740285
[TBL] [Abstract][Full Text] [Related]
14. Changes in Tear Volume after 3% Diquafosol Treatment in Patients with Dry Eye Syndrome: An Anterior Segment Spectral-domain Optical Coherence Tomography Study.
Lee KB; Koh KM; Kwon YA; Song SW; Kim BY; Chung JL
Korean J Ophthalmol; 2017 Aug; 31(4):306-312. PubMed ID: 28752695
[TBL] [Abstract][Full Text] [Related]
15. Effect of diquafosol three per cent ophthalmic solution on tear film and corneal aberrations after cataract surgery.
Lee H; Kim SM; Choi S; Seo KY; Kim EK; Kim TI
Clin Exp Optom; 2017 Nov; 100(6):590-594. PubMed ID: 28222481
[TBL] [Abstract][Full Text] [Related]
16. The Efficacy of Diquafosol Ophthalmic Solution in Non-Sjögren and Sjögren Syndrome Dry Eye Patients Unresponsive to Artificial Tear.
Jeon HS; Hyon JY
J Ocul Pharmacol Ther; 2016 Sep; 32(7):463-8. PubMed ID: 27294831
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of the effect of diquafosol ophthalmic solution in glaucoma patients with dry eye syndrome.
Jin SW; Min JS
Jpn J Ophthalmol; 2016 May; 60(3):150-5. PubMed ID: 26873225
[TBL] [Abstract][Full Text] [Related]
18. Effect of diquafosol tetrasodium eye drop for persistent dry eye after laser in situ keratomileusis.
Mori Y; Nejima R; Masuda A; Maruyama Y; Minami K; Miyata K; Amano S
Cornea; 2014 Jul; 33(7):659-62. PubMed ID: 24858017
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Safety and Effectiveness of Diquafosol for the Treatment of Dry Eye in a Real-World Setting: A Prospective Observational Study.
Ohashi Y; Munesue M; Shimazaki J; Takamura E; Yokoi N; Watanabe H; Nomura A; Shimada F
Adv Ther; 2020 Feb; 37(2):707-717. PubMed ID: 31834617
[TBL] [Abstract][Full Text] [Related]
20. Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.
Yamane M; Ogawa Y; Fukui M; Kamoi M; Saijo-Ban Y; Yaguchi S; Mukai S; Kawakita T; Simmura S; Tsubota K
Optom Vis Sci; 2015 Apr; 92(4 Suppl 1):S25-32. PubMed ID: 25785527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
